No Detail Found!

Role of Bevacizumab for Prevention of Neovascular Glaucoma in Acute Retinal Vein Occlusion.

Author(s)
Bassam Mubarik Department of Ophthalmology Madinah Teaching Hospital Faisalabad, Pakistan
Adeen Akram Allied Hospital, Faisalabad, Pakistan
Abstract
There is a possibility of developing neovascular glaucoma in ischemic type of retinal vein occlusion. Purpose of the study is to determine the role of anti VEGF agent bevacizumab for prevention of neovascular glaucoma in ischemic type of retinal vein occlusion. METHOD: It was a retrospective study of 34 cases with unilateral central retinal vein occlusion. All of them were treated with intra vitreous Bevacizumab for management of associated macular edema. Primary outcome was to study development of neovascular glaucoma in these cases. RESULTS: Thirty four cases were selected with retinal vein occlusion. Seventeen cases were of non ischemic type and remaining 17 were of ischemic type vein occlusion. During a follow up period of two years non ischemic group was given on average 8 bevacizumab injection. Only one of these non ischemic eyes developed neo vessels of optic disc but neo vascular glaucoma did not develop. In case of ischemic group during follow up period of two years a mean of 6 bevacizumab injections were given. In this ischemic group 2 cases developed iris neovesseles and 3 cases developed retinal neovesseles. Out of these, three eyes progressed to neovascular glaucoma. CONCLUSION: Bevacizumab treatment of macular edema for ischemic central retinal vein occlusion does not prevent neovascular glaucoma.
Publication Details
Page(s) 64-67
DOI DOI not available
Published Journal: Journal of University Medical & Dental College, Volume: 9, Issue: 1, Year: 2018

Request the full text from PASTIC

References
Knudtnon Md, 2007.Retinal vein occlusion and vascular mortality: pooled data analysis of 2 population based cohorts,Ophthalmology 114 520 -524
1997.Natural history and clinical management of central vein occlusion,Archives of ophthalmology 115 486 -491
S.S.Hayreh,M.R.Klugman,M.Beri,A.E.Kimura,P.Podhajsky, 1996.Differentiation of ischemic from non ischemic central retinal vein occlusion during early acute phase. G r a e f e ' s A r c h i v e o f c l i n i c a l a n d experimental ophthalmology, 228 201 -217
S. L.Roger, 2010.natural history of retinal vein occlusion: Evidence based systemic review,Ophthalmology 117 1113 -1123
L.P.Aiello,R.L.Avery,P.G.Arrigg, 1994.vascular endothelial growth factor in ocular of patients with diabetic retinopathy and other retinal disorders,New England journal of medicine 331 1480 -1487
L.P.Aiello,R.L.Avery,P.G.Arrigg, 1994.Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders,New England journal of medicine 331 1480 -1487
M.E.Ilieve,D., 2006.Sarra, intravitreal b e va c i z u m a b i n t h e t r e a t m e n t o f neovascular glaucoma,American journal of ophthalmology 142 1054 -56
J.Beutel,S.Peters,M.Luke, 2010.Bevacizumab as adjuvant for neovascular glaucoma,Acta ophthalmologica 88 103 -109
P.A.Campochiaro,j.S.Heier,L.Feiner, 2010.Ranibizumab for macular edema following branch retinal vein occlusion,Ophthalmology 117 1102 -1112
D.M. Brown , P.A. campochiaro, R.P.,Singh, .Ranibizumab for macular edema following central retinal vein occlusion,Ophthalmology 2110 1124 -1133
Beutel , F.,Ziemssen , M.,Luke , M.,Schmidth , F., 2010.G elisken, intravitreal bevacizumab treatment of macular edema in central retinal vein occlusion : one year results,International ophthalmology 30 15 -22
S.S.Hayresh and M.B Zimmerman, 2012.Ocular neovascularization associated with central and hemi central retinal vein occlusion,Retina 32 1553 -
C.K.Chan , M.S. I. P., 2011.: incidence of neovascular events in eyes with retinal vein occlusion,Ophthalmology 118 1364 -1372
H.J. Sohn , D.H.,Han , D.Y.,Lee, 2013.changes in aqueous cytokines after intravitreous triamcinolone versus bevacizumab for macular edema in branch retinal occlusion,Acta Ophthalmologica -
Noma , H.,Funatsu and T.,Mimura, 2013.Changes of inflammatory factors after intravitreous triamcinolone acetonoid for macular edema with central retinal vein occlusion,Journal of ocular pharmacology and therapeutics 29 363 -365
0

Citations

0

Downloads

34

Views